Mechanisms of lymphocyte-mediated cytotoxicity in acute renal allograft rejection. 1998

P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
Renal Transplant Unit, Academic Medical Center, University of Amsterdam, The Netherlands.

BACKGROUND Graft-infiltrating T-cell (GIC) lines cultured from biopsies obtained during acute renal allograft rejection exhibit donor-specific cytotoxicity toward proximal tubular epithelial cell (PTEC) lines cultured from corresponding biopsies. This system allows for study of the relative contributions of perforin/granzyme B (GrB)- and Fas ligand (FasL)-based cytotoxicity to killing of PTEC. METHODS Expression of perforin, GrB and FasL was analyzed by immunocytochemical staining of cytocentrifuge preparations of GIC lines cultured from 10 renal allograft biopsies. Specific inhibitors of the perforin/GrB- and FasL-based pathways were used in 51Cr release and apoptosis assays to determine their relative contributions to cytotoxicity of GIC lines toward corresponding donor PTEC lines. RESULTS Cells with a strong granular pattern were observed upon immunocytochemical staining of GIC lines with anti-perforin or anti-GrB monoclonal antibodies. A diffuse staining pattern was observed upon staining with anti-FasL polyclonal antibodies. Six of eight GIC lines cultured from biopsies with acute rejection showed cytotoxicity toward corresponding donor PTEC lines, whereas two GIC lines cultured from biopsies without rejection did not. Preincubation of cytotoxic GIC lines with concanamycin A, an inhibitor of the perforin/GrB-based pathway, caused inhibition of both lysis and apoptosis of PTEC. Inhibition was not observed upon incubation with monoclonal antibodies that inhibit Fas. CONCLUSIONS The perforin/GrB-based pathway is mainly responsible for cytotoxicity of GIC lines toward corresponding donor PTEC lines, suggesting that this pathway predominates in tubular epithelial cell destruction by cytotoxic T lymphocytes during acute renal allograft rejection in vivo.

UI MeSH Term Description Entries
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
June 1988, Transplantation proceedings,
P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
March 1971, Transplantation proceedings,
P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
February 1998, The Surgical clinics of North America,
P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
February 1998, Transplantation proceedings,
P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
August 1990, Transplantation,
P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
July 1974, Transplantation,
P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
December 1996, Transplantation proceedings,
P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
February 1996, Transplantation proceedings,
P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
May 2008, Transplantation proceedings,
P C Wever, and J G Boonstra, and J C Laterveer, and C E Hack, and F J van der Woude, and M R Daha, and I J ten Berge
January 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!